Dietary Guidelines to Improve Cardiovascular Health in 2021

Dieta proinflamatoria y su potencial para desencadenar eventos cardiovasculares

A poor diet is associated with high risk of heart disease, morbidity and mortality

This scientific document emphasizes the importance of a dietary pattern beyond food or nutrients: it highlights the critical role of early nutrition, presents us with elements to build healthy eating habits and underscores the need to introduce structural changes to achieve adherence to a balanced diet. 

A healthy dietary pattern based on evidence capable of promoting cardiometabolic health includes the following:

  • Adjusting calory consumption to calory expenditure to achieve and mantain a healthy weight.
  • Eating abundant and varied fruits and vegetables. 
  • Choosing whole grain products and foods.
  • Choosing healthy proteins (mostly plants and regularly fish and seafood). Choosing fat free or low-fat foods. 
  • Choosing lean cuts or the least processed, when consuming red meats or poultry,

Read also: Saturated Fats: Dietary Angels or Demons?


  • Using liquid vegetable oils instead of tropical or partially hydrogenated oils.  
  • Eating the least possible amount of processed food and avoiding ultra-processed food altogether. 
  • Avoiding beverages and foods with added sugar. 
  • Choosing and preparing food with the least possible amount of salt (if possible, no salt at all). 
  • Limiting alcohol consumption or avoiding it altogether, preferably. 
  • Adhering to these guidelines regardless of where the food is prepared or consumed. 

The obstacles that might conspire against following the above-mentioned points are advertising of unhealthy food, and poor access to healthy food markets, which might not be available within reasonable distance (reachable on foot). 

Poor nutrition is only the tip of the iceberg; a lot more people cannot access any kind of food. 

CIR-0000000000001031

Original Title: 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association.

Reference: Alice H. Lichtenstein et al. Circulation. 2021 Nov 2;CIR0000000000001031. doi: 10.1161/CIR.0000000000001031. Online ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...